FSD STUDY DATA

A cross sectional study with 200 gynaecological cancer survivors was conducted who attended gynaecological cancer clinic at a tertiary care center. These survivors underwent laboratory assessment for neurotropic factors (Brain derived neurotropic factor, Neuropeptide Y and Substance P ) and Female Sexual Function Index (FSFI) questionnaire assessment. Then evaluate the prevalence of sexual dysfunction in gynaecological cancer survivor, determine risk factors for sexual dysfunction, correlation between female sexual dyfunction and subdomains of female sexual function index (desire, arousal, lubrication, orgasm, satisfaction and sexual pain) with neurotropic factors was done.